Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat cancers, announced today that management will participate virtually in the following investor conferences during August 2022:
2022 BTIG Biotechnology Conference, August 8-9, 2022
- Sapience management will participate virtually in one-on-one meetings with investors on August 9.
2022 Wedbush PacGrow Healthcare Conference, August 9-10, 2022
- Sapience management will participate virtually in a fireside chat with Robert Driscoll, Research Analyst at Wedbush, on August 10 at 8:35 am ET. Company management will also participate in virtual one-on-one meetings with investors on the same day.
